Two Inhibitors of DNA‐Synthesis Lead to Inhibition of Cytokine Production via a Different Mechanism
Authors:
- A. H. GerardsAGA. H. Gerards
- B. A.C. DijkmansBDB. A.C. Dijkmans
- L. A. AardenLAL. A. Aarden
- 31 December 2004
- journal article
- review article
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 23 (8-9) , 1089-1100
Abstract
Methotrexate (MTX) and mycophenolic acid (MPA) are used in the clinic for their immunosuppressive properties. MTX is widely used for the treatment of rheumatoid arthritis (RA). MPA is used to prevent graft rejection and is now experimentally used in systemic lupus erythematosis and RA. It is known that both drugs interfere with DNA synthesis. However, the precise mechanism of action is still debated. We have analysed the effect of the drugs on cytokine production in whole blood during short cultures. The production of T-cell cytokines was inhibited by both drugs. MTX inhibits cytokine production because MTX induces apoptosis in activated T-cells. MPA inhibits cytokine production by preventing T-cells to progress to the S-phase of the cell cycle. Cytokine production by monocytes was slightly decreased by the drugs. The reason for this inhibition is not clear. These results indicate that T-cells are the main target cells of the immunosuppressive drugs MPA and MTKeywords
This publication has 40 references indexed in Scilit:
- Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritisRheumatology, 2003
- Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX‐68Arthritis & Rheumatism, 2003
- Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: Evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritisArthritis & Rheumatism, 2000
- Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?Biochemical Journal, 1999
- Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: A comparative study using anti‐TNFα, anti–IL‐1α/β, and IL‐1RaArthritis & Rheumatism, 1996
- Mechanisms of Action of Mycophenolic AcidAnnals of the New York Academy of Sciences, 1993
- Low‐dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. results of a multicenter randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 1993
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Polyglutamation of methotrexate. Is methotrexate a prodrug?Journal of Clinical Investigation, 1985